rs34962745
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_022081.6(HPS4):c.751A>T(p.Thr251Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00924 in 1,613,952 control chromosomes in the GnomAD database, including 92 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0069 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0095 ( 83 hom. )
Consequence
HPS4
NM_022081.6 missense
NM_022081.6 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 4.57
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0051202774).
BP6
Variant 22-26465507-T-A is Benign according to our data. Variant chr22-26465507-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 341016.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2, Benign=3}. Variant chr22-26465507-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00694 (1057/152208) while in subpopulation AMR AF= 0.0124 (189/15298). AF 95% confidence interval is 0.0109. There are 9 homozygotes in gnomad4. There are 468 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS4 | NM_022081.6 | c.751A>T | p.Thr251Ser | missense_variant | 10/14 | ENST00000398145.7 | NP_071364.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS4 | ENST00000398145.7 | c.751A>T | p.Thr251Ser | missense_variant | 10/14 | 1 | NM_022081.6 | ENSP00000381213.2 |
Frequencies
GnomAD3 genomes AF: 0.00694 AC: 1056AN: 152090Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
1056
AN:
152090
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00731 AC: 1839AN: 251474Hom.: 7 AF XY: 0.00753 AC XY: 1024AN XY: 135916
GnomAD3 exomes
AF:
AC:
1839
AN:
251474
Hom.:
AF XY:
AC XY:
1024
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00948 AC: 13862AN: 1461744Hom.: 83 Cov.: 31 AF XY: 0.00929 AC XY: 6754AN XY: 727178
GnomAD4 exome
AF:
AC:
13862
AN:
1461744
Hom.:
Cov.:
31
AF XY:
AC XY:
6754
AN XY:
727178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00694 AC: 1057AN: 152208Hom.: 9 Cov.: 33 AF XY: 0.00629 AC XY: 468AN XY: 74412
GnomAD4 genome
AF:
AC:
1057
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
468
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
52
ALSPAC
AF:
AC:
34
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
94
ExAC
AF:
AC:
878
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hermansky-Pudlak syndrome 4 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | May 29, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Dec 10, 2020 | - - |
Oculocutaneous albinism Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetics - Synnovis, NHS South East Genomic Laboratory Hub | Dec 21, 2016 | This variant may be associated with cardiomyopthy. There 3 individuals present in the ExAC database that are homozygous for this variant. Insufficient evidence to move out of uncertain significance classification. - |
Hermansky-Pudlak syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Thr251Ser in exon 10 of HPS4: This variant is not expected to have clinical sign ificance because it has been identified in 1.1% (94/8600) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs34962745). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;.;M;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;.
Polyphen
B;B;B;.
Vest4
MutPred
Gain of disorder (P = 0.0551);.;Gain of disorder (P = 0.0551);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at